Prof. Varda Shalev
With over 30 years of hands-on experience in primary care, epidemiology, medical informatics, digital health investing, and medical research, Prof. Varda Shalev brings unique insights, expertise, and experience in healthcare technologies and innovation to the Board.
Prof. Shalev joined the Teva Board of Directors in September 2023.
Prof. Shalev is a Managing Partner at Team8 Health, a leading Venture Capital firm in Israel that invests and builds disruptive and innovative healthcare technologies, since 2022. She has also been a Co-Founder and an Advisory Board Member at Alike.Health, a digital health startup aiming to revolutionize patient care through technology, since 2020. Prof. Shalev has been a Full Professor of Epidemiology at the Tel Aviv University School of Public Health since 2013 and an active primary care physician since 1993. Prior to her current roles, Prof. Shalev founded and led KSM, the research and innovation center of Maccabi Health Services. She has also founded the largest Biobank in Israel at Maccabi Healthcare Services.
Prof. Shalev has served as a board member at BATM Advanced Communications Ltd. since 2018. She previously served on the board of directors of Pluristem Therapeutics Inc. from 2021 to 2023, and on the board of directors of Novolog Pharm Up 1996 Ltd. from 2022 to 2023.
Prof. Shalev has a track record of implementing innovative solutions to improve patient care and organizational efficiency. She pioneered the development of medical informatics in Israel and was key in planning and developing its computerized medical systems, physicians' and patients' portals registries, and decision support systems.
With over 200 published peer-reviewed articles in top medical journals, Prof. Shalev has contributed to medicine and medical informatics. Her work in this area has been the subject of a Harvard Business School case study (N1-819-032).